Several autophagy inhibitors have been developed as potential anti-cancer drugs such as chloroquine or ULK1 inhibitors (Chude and Amaravadi, 2017; Martin et al., 2018), exploiting metabolic requirement of cancer cells. This evidence concerns the gene ULK1 and cancer.